Clinical Trials Logo

Filter by:
NCT ID: NCT04689659 Recruiting - Relapse/Recurrence Clinical Trials

Multi-centers, Open-Label, Phase 2 Study to Evaluate the Efficacy and Safety of Donor-Derived CD7 CAR T Cells in Subjects With Relapsed or Refractory T-cell Leukemia/Lymphoma

Start date: February 1, 2021
Phase: Phase 2
Study type: Interventional

This is a multi-centers, single-arm, open label, Phase 2 clinical trial to evaluate the efficacy and safety of CD7 CAR T cells in subjects with relapsed or refractory T-cell leukemia/lymphoma. Seventy subjects will be enrolled. CD7 CAR T cells will be given once intravenously at one dose (1×106, with an allowance of ± 20%) in patients received previous HSCT donor-derived CAR T cells. Patients who received fresh donor derived CD7 CAR T cells were given initial dose of 1×106, with an allowance of ± 20%. The dose levels may be adjusted during the study based on the specific number of cells on the day of fresh CAR T cells infusion, due to at this time all the patients have completed lymphodepleting, so we adopt the allowance of ±20% for each group of absolute infusion cells. And patients who were lower than the designed dose group were also given infusion, but they will be either assigned to the lower dose group or exclude from safety analysis of designed dose group.

NCT ID: NCT04689425 Recruiting - Diabetic Foot Ulcer Clinical Trials

Umbilical Cord Blood Mononuclear Cell Gel in the Treatment of Refractory Diabetic Foot Ulcer

DFU-MNC
Start date: March 30, 2021
Phase: Phase 3
Study type: Interventional

Umbilical cord blood mononuclear cells (MNC) may improve the wound repair ability. This study aims to investigate the role of MNC in refractory diabetic foot ulcer by comparing the combination of PRP and MNC with PRP alone.

NCT ID: NCT04689308 Recruiting - Clinical trials for Relapsed/Refractory B-cell Malignancies

This is a Phase 1 Study of MH048 in Patients With Selected Relapsed/Refractory B-cell Malignancies

Start date: January 7, 2021
Phase: Phase 1
Study type: Interventional

This is a Phase 1 study of MH048 in patients with selected Relapsed/Refractory B-cell Malignancies.

NCT ID: NCT04689243 Recruiting - Skin Ulcer Clinical Trials

Low Concentration ALA-PDT in Treatment of Skin Ulcer

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

Skin ulcer is a common disease with complicated etiopathogenes, which makes it hard to be cured. It has been reported that photodynamic therapy (PDT) can be used to treat skin ulcers which were caused by different diseases. However, PDT is an expensive treatment and patients always experience obvious pain during or after the treatment, which hinders the application of PDT in skin ulcer. Our previous study found that PDT using a low concentration of 5-Aminolevulinic acid (ALA) could promote the healing of skin ulcer without obvious adverse reactions, which suggests us that low concentration ALA-PDT might be an efficient and cost effective treatment in skin ulcer. To further investigate the use of low concentration ALA-PDT in skin ulcer, we plan to recruit patients with skin ulcers caused by different diseases, and divide these patients into different groups according to their causes of disease, and then treat them using low concentration ALA-PDT to observe the healing process of skin ulcer. This study could further optimize and promote the use of low concentration ALA-PDT in skin ulcer.

NCT ID: NCT04689204 Recruiting - Clinical trials for Acute Lymphoblastic Leukemia

A Study of CTA30X Cell Injection in Patients With Relapsed or Refractory CD19-positive B-line Hematological Malignancies

Start date: December 29, 2020
Phase: Early Phase 1
Study type: Interventional

A study of CTA30X cell injection in the treatment of relapsed or refractory CD19-positive B-line hematological malignancies

NCT ID: NCT04689191 Recruiting - Clinical trials for Meningitis, Meningococcal

A Phase III Clinical Trial of the Group A and C Meningococcal Polysaccharide Vaccine

Start date: September 15, 2020
Phase: Phase 3
Study type: Interventional

This study is a randomized, double-blinded, and controlled phase III clinical trial of the Group A and C meningococcal polysaccharide vaccine to evaluate the safety and immunogenicity of the vaccine in healthy infants aged 2-6 years.

NCT ID: NCT04689165 Recruiting - Clinical trials for Meningitis, Meningococcal

A Phase III Clinical Trial of the Group A Meningococcal Polysaccharide Vaccine

Start date: September 14, 2020
Phase: Phase 3
Study type: Interventional

This study is a randomized, double-blinded, and controlled phase III clinical trial of the Group A meningococcal polysaccharide vaccine to evaluate the safety and immunogenicity of the vaccine in healthy infants aged 6-15 months.

NCT ID: NCT04689100 Recruiting - Clinical trials for Advanced Solid Tumor

Efficacy and Safety of JMT101 in Patients With Advanced Solid Tumor

Start date: April 11, 2017
Phase: Phase 1
Study type: Interventional

This study is a Phase I, open label, multi-center study of to evaluate the safety and efficacy of JMT101 in patients with advanced solid tumor.

NCT ID: NCT04689087 Recruiting - Clinical trials for Recurrent Glioblastoma Multiforme

A Prospective, Open-label, Single-arm Clinical Study

Start date: April 1, 2020
Phase: N/A
Study type: Interventional

the study is a prospective, single-arm, open-label trial, designed to explore the efficacy and safety of Tumor-Treating Fields (TTFields) combined with second-line chemotherapy treatment in recurrent glioblastoma multiforme (GBM) , TTFields is an portable, battery operated device for chronic treatment of patients with recurrent or progressive glioblastoma multiforme (GBM) using alternating electric fields

NCT ID: NCT04688944 Recruiting - Clinical trials for Lumbar Spinal Stenosis

The Correlation Between Degeneration of Paraspinal Muscle and Outcome of Patients With Lumbar Spinal Stenosis

Start date: October 12, 2020
Phase:
Study type: Observational

The photographical and functional parameters of paravertebral muscle in patients with lumbar spinal stenosis will be measured to investigate the correlation between paravertebral muscle degeneration and symptoms and prognosis of patients.By measuring the parameters of paravertebral muscle with normal people, the differences between the patients and normal people will be compared to establish an appropriate paravertebral muscle evaluation method.